Exane BNP Paribas upgraded Comcast (CMCSA) to Neutral from Underperform with a $35 price target Invest with Confidence: Follow TipRanks' Top ...

Osta Therapeutics, a biotechnology company developing smart drugs to fight antibiotic resistance, today announced the appointments of Dr. Gilles Courtemanche as Senior Scientific Advisor and Dr.

Half-year report on IPSOS’ liquidity contract with Exane BNP PARIBAS Under the liquidity contract entrusted by IPSOS SA to Exane BNP Paribas, the following assets appeared on the liquidity account as ...

Exane BNP Paribas analyst Karl Ackerman upgraded Cisco (CSCO) to Outperform from Neutral with a price target of $72, up from $57. The firm sees ...

London stocks were steady in early trade on Thursday as investors mulled a slide UK in consumer confidence. At 0830 GMT, the ...

Citigroup cuts Associated British foods to 'sell' - price target 1,770 pence UBS cuts JD Sports Fashion to 'neutral' (buy) - price target 103 (155) pence Deutsche Bank Research cuts JD Sports ...

The upcoming US listing could broaden its investor base. BNPP Exane analyst William Packer has closely watched UMG and its stock performance for years. He said this morning in a research note that he ...

Exane BNP Paribas upgraded Adobe Inc. (NASDAQ:ADBE) to Neutral from Underperform and raised the stock's price target to $425. The analyst views better risks and rewards consideration on Adobe for its ...

Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for Novo Nordisk A (OTCPK:NONOF) from Neutral to Outperform. Analyst Price Forecast Suggests 2.43% Downside As of ...

Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for flatexDEGIRO (OTCPK:FNNTF) from Neutral to Outperform. Analyst Price Forecast Suggests 5.46% Upside As of March ...